Drug Screening

We present fundamental solutions for intractable neurological diseases through innovative iPSC technology.

  • TECHNOLOGY & INNOVATION
  • Drug Screening

Unlocking new possibilities
in drug discovery

Schematic diagram of the current progress in screening effective drugs for Alzheimer's and Huntington's diseases
Patient iPSC-Derived
Screening Platforms
Image-Based
High-Content Screening

High-Contecnt Screening (HCS)

Validation of
Mode of Action
  • DAPI
  • Nestin
  • 1C2
  • Merge
Results of IXMC (Integrated X-ray Micro-CT) and filter trap assay for candidate drug selection

Introduction of a screening system using patient-derived induced pluripotent stem cells (iPSCs)

Discovery of potential compounds for Alzheimer's and Huntington's disease through screening methods

Validation of new drug potential through mechanism research and efficacy verification of the discovered dementia drug candidates

Generation of Reporter iPSC Lines
Drug Screening using Reporter iPSC Lines